A simple mycobacterial monomycolated glycerol lipid has potent immunostimulatory activity

Journal of Immunology

Volumn 182, Issue 1, 2009, Pages 424-432

  Andersen, Claire S ^a   Agger, Else Marie ^a   Rosenkrands, Ida ^a   Gomes, Jessica M ^b   Bhowruth, Veemal ^b   Gibson, Kevin J C ^b   Petersen, Rune V ^a   Minnikin, David E ^b   Besra, Gurdyal S ^b   Andersen, Peter ^a  

^a STATENS SERUM INSTITUT   (Denmark)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; BACTERIAL PROTEIN; BCG VACCINE; CARBON; CARBON 32; CATION; CYTOKINE; GAMMA INTERFERON; LIPOSOME; MONOMYCOLYL GLYCEROL; UNCLASSIFIED DRUG; CORD FACTOR; CORYNOMYCOLIC ACID; CORYNOMYCOLOYL D TREHALOSE; CORYNOMYCOLOYL-D-TREHALOSE; GLYCEROL; GLYCOLIPID; IMMUNOLOGICAL ADJUVANT; MYCOLIC ACID;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DRUG DELIVERY SYSTEM; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNIZATION; IMMUNOSTIMULATION; MOUSE; MYCOBACTERIUM BOVIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH1 CELL; ANIMAL; C57BL MOUSE; CELL CULTURE; CHEMISTRY; COMPARATIVE STUDY; CORYNEBACTERIUM DIPHTHERIAE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MICROBIOLOGY; MYCOBACTERIUM TUBERCULOSIS;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BCG VACCINE; CELLS, CULTURED; CORD FACTORS; CORYNEBACTERIUM DIPHTHERIAE; DENDRITIC CELLS; FEMALE; GLYCEROL; GLYCOLIPIDS; HUMANS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; MYCOLIC ACIDS; TH1 CELLS;

EID: 59849124393     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.182.1.424     Document Type: Article

References (32)

1. Nathan, C., H. Murray, M. Wiebe, and B. Rubin. 1983. Identification of interferon-γ as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J. Exp. Med. 158: 670-689.
2. Hart, P., M. Young, A. Gordon, and K. Sullivan. 1987. Inhibition of phagosome-lysosome fusion in macrophages by certain mycobacteria can be explained by inhibition of lysosomal movements observed after phagocytosis. J. Exp. Med. 166: 933-946.
3. Flynn, J. L., and J. Chan. 2005. What's good for the host is good for the bug. Trends Microbiol. 13: 98-102.
4. Sprott, G. D., C. J. Dicaire, K. Gurnani, S. Sad, and L. Krishnan. 2004. Activation of dendritic cells by liposomes prepared from phosphatidylinositol mannosides from Mycobacterium bovis bacillus Calmette-Guérin and adjuvant activity in vivo. Infect. Immun. 72: 5235-5246.
5. Reed, M. B., P. Domenech, C. Manca, H. Su, A. K. Barczak, B. N. Kreiswirth, G. Kaplan, and C. E. Barry, III. 2004. A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response. Nature 431: 84-87.
6. Geisel, R. E., K. Sakamoto, D. G. Russell, and E. R. Rhoades. 2005. In vivo activity of released cell wall lipids of Mycobacterium bovis bacillus Calmette-Guérin is due principally to trehalose mycolates. J. Immunol. 174: 5007-5015.
7. Manca, C., L. Tsenova, C. E. Barry, III, A. Bergtold, S. Freeman, P. A. Haslett, J. M. Musser, V. H. Freedman, and G. Kaplan. 1999. Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates. J. Immunol. 162: 6740-6746.
8. Dobson, G., D. E. Minnikin, S. M. Minnikin, J. H. Parlett, M. Goodfellow, and M. Ridell. 1985. Systematic analysis of complex mycobacterial lipids. In Chemical Methods in Bacterial Systematics. M. Goodfellow and D. E. Minnikin, eds. Academic Press, London, UK, p. 237.
9. Rosenkrands, I., E. M. Agger, A. W. Olsen, K. S. Korsholm, C. S. Andersen, K. T. Jensen, and P. Andersen. 2005. Cationic liposomes containing mycobacterial lipids: a new powerful Th1 adjuvant system. Infect. Immun. 73: 5817-5826.
10. Minnikin, D. E. 1988. Isolation and purification of mycobacterial wall lipids. In Bacterial Cell Surface Techniques. I. C. Hancock, I. R. Poxton, eds. Wiley, Chichester, U.K., p. 125.
11. Romani, N., S. Gruner, D. Brang, E. Kampgen, A. Lenz, B. Trockenbacher, G. Konwalinka, P. Fritsch, R. Steinman, and G. Schuler. 1994. Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 180: 83-93.
12. Olsen, A. W., L. A. H. van Pinxteren, L. M. Okkels, P. B. Rasmussen, and P. Andersen. 2001. Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85B and ESAT-6. Infect. Immun. 69: 2773-2778.
13. Gunstone, F. D. 1991. 13C-NMR studies of mono-, di- and tri-acylglycerols leading to qualative and semiqualative information about mixtores of these glycerol esters. Chem. Phys. Lipids 58: 219-224.
14. Cox, J. S., B. Chen, M. McNeil, and W. R. Jacobs, Jr. 1999. Complex lipid determines tissue-specific replication of Mycobacterium tuberculosis in mice. Nature 402: 79-83.
15. Silva, C. 1985. Inflammation induced by mycolic acid-containing glycolipids of Mycobacterium bovis (BCG). Braz. J. Med. Biol. Res. 18: 327-335.
16. Yamagami, H., T. Matsumoto, N. Fujiwara, T. Arakawa, K. Kaneda, I. Yano, and K. Kobayashi. 2001. Trehalose 6,6′-dimycolate (cord factor) of Mycobacterium tuberculosis induces foreign-body- and hypersensitivity- type granulomas in mice. Infect. Immun. 69: 810-815.
17. Rao, V., N. Fujiwara, S. A. Porcelli, and M. S. Glickman. 2005. Mycobacterium tuberculosis controls host innate immune activation through cyclopropane modification of a glycolipid effector molecule. J. Exp. Med. 201: 535-543.
18. Villeneuve, M., M. Kawai, H. Kanashima, M. Watanabe, D. E. Minnikin, and H. Nakahara. 2005. Temperature dependence of the Langmuir monolayer packing of mycolic acids from Mycobacterium tuberculosis. Biochim. Biophys. Acta 1715: 71-80.
19. Datta, A. K., K. Takayama, M. A. Nashed, and L. Anderson. 1991. An improved synthesis of trehalose 6-mono- and 6,6′-di-corynomycolates and related esters. Carbohydr. Res. 218: 95-109.
20. Agger, E. M., I. Rosenkrands, J. Hansen, K. Brahimi, B. S. Vandahl, C. Aagaard, K. Werninghaus, C. Kirschning, R. Lang, D. Christensen, et al. 2008. Cationic liposomes formulated with synthetic mycobacterial cordfactor (CAF01): a versatile adjuvant for vaccines with different immunological requirements. PLoS ONE 3: e3116.
21. Brightbill, H. D., D. H. Libraty, S. R. Krutzik, R. B. Yang, J. T. Belisle, J. R. Bleharski, M. Maitland, M. V. Norgard, S. E. Plevy, S. T. Smale, et al. 1999. Host defense mechanisms triggered by microbial lipoproteins through Toll-like receptors. Science 285: 732-736.
22. Hertz, C. J., S. M. Kiertscher, P. J. Godowski, D. A. Bouis, M. V. Norgard, M. D. Roth, and R. L. Modlin. 2001. Microbial lipopeptides stimulate dendritic cell maturation via Toll-like receptor 2. J. Immunol. 166: 2444-2450.
23. Tenu, J. P., D. Sekkai, A. Yapo, J. F. Petit, and G. Lemaire. 1995. Phosphatidylinositol-mannoside-based liposomes induce no synthase in primed mouse peritoneal macrophages. Biochem. Biophys. Res. Commun. 208: 295-301.
24. Davidsen, J., I. Rosenkrands, D. Christensen, A. Vangala, D. Kirby, Y. Perrie, E. M. Agger, and P. Andersen. 2005. Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6′-dibehenate): a novel adjuvant inducing both strong CMI and antibody responses. Biochim. Biophys. Acta 1718: 22-31.
25. Holten-Andersen, L., T. M. Doherty, K. S. Korsholm, and P. Andersen. 2004. Combination of the cationic surfactant dimethyl dioctadecyl ammonium bromide and synthetic mycobacterial cord factor as an efficient adjuvant for tuberculosis subunit vaccines. Infect. Immun. 72: 1608-1617.
26. Asselineau, J. 1966. The Bacterial Lipids. Hermann, Paris. 27. Bloch, H., J. Defaye, E. Lederer, and H. Noll. 1957. Constituents of a toxic-lipid obtained from Mycobacterium tuberculosis. Biochim. Biophys. Acta 23: 312-321.
27. Gastambide-Odier, M. 1973. Characterisation of mycoside variants using glycoside residues substituted with acylated chains: mycolic nature of mycoside G′. Eur. J. Biochem. 33: 81-86.
28. Quesniaux, V., C. Fremond, M. Jacobs, S. Parida, D. Nicolle, V. Yeremeev, F. Bihl, F. Erard, T. Botha, M. Drennan, et al. 2004. Toll-like receptor pathways in the immune responses to mycobacteria. Microbes Infect. 6: 946-959.
29. Jo, E. K., C. S. Yang, C. H. Choi, and C. V. Harding. 2007. Intracellular signalling cascades regulating innate immune responses to Mycobacteria: branching out from Toll-like receptors. Cell Microbiol. 9: 1087-1098.
30. Korf, J., A. Stoltz, J. Verschoor, P. De Baetselier, and J. Grooten. 2005. The Mycobacterium tuberculosis cell wall component mycolic acid elicits pathogen-associated host innate immune responses. Eur. J. Immunol. 35: 890-900.
31. Baldridge, J. R., P. McGowan, J. T. Evans, C. Cluff, S. Mossman, D. Johnson, and D. Persing. 2004. Taking a Toll on human disease: Toll-like receptor 4 agonists as vaccine adjuvants and monotherapeutic agents. Expert Opin. Biol. Ther. 4: 1129-1138.
32. Jarrossay, D., G. Napolitani, M. Colonna, F. Sallusto, and A. Lanzavecchia. 2001. Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells. Eur. J. Immunol. 31: 3388-3393.